Table 2.
(A) Multivariable logistic regression analysis for AAC in patients with CKD Stages 1–4. (B) Multivariable logistic regression analysis for CVC in patients with CKD Stages 1–4.
| Characteristic | OR | 95%CI | P |
|---|---|---|---|
| (A) | |||
| Age, per 1 year increase | 1.08 | 1.06–1.10 | <0.001 |
| Gender, male vs. female | 0.63 | 0.39–1.01 | 0.05 |
| BMI, per 1 kg/m2 | 1.01 | 0.96–1.06 | 0.838 |
| History of CVD, yes vs. no | 1.76 | 1.20–2.59 | 0.004 |
| Tobacco use, yes vs. no | 1.73 | 1.10–2.70 | 0.03 |
| Hemoglobin, per 1 g/L increase | 0.99 | 0.98–1.00 | 0.003 |
| Serum albumin, per 1 g/L increase | 1.03 | 1.00–1.07 | 0.08 |
| 24–h urine protein, per 1 natural log increase (g/24 h) | 1.09 | 0.95–1.25 | 0.22 |
| Hypertension, yes vs. no | 1.90 | 1.08–3.32 | 0.03 |
| Diabetes, yes vs. no | 1.87 | 1.33–2.65 | <0.001 |
| Triglyceride, per 1 natural log increase (mmol/L) | 1.01 | 0.73–1.40 | 0.95 |
| Cholesterol, per 1 natural log increase (mmol/L) | 0.72 | 0.43–1.20 | 0.21 |
| LDL–C, per 1 natural log increase (mmol/L) | 1.89 | 1.11–3.21 | 0.02 |
| eGFR, per 1 ml/min/1.73m2 increase | 1.003 | 0.995–1.010 | 0.50 |
| Serum uric acid, per 1 umol/L increase | 1.002 | 1.000–1.004 | 0.02 |
| Serum calcium, per 1 mmol/L increase | 0.61 | 0.21–1.77 | 0.36 |
| Serum phosphorus, per 1 natural log increase (mmol/L) | 0.98 | 0.43–2.24 | 0.97 |
| IPTH, per 1 natural log increase (pg/ml) | 0.94 | 0.72–1.23 | 0.65 |
| Calcium–free phosphorus binder, yes vs. no | 0.75 | 0.44–1.26 | 0.27 |
| Active vitamin D, yes vs. no | 0.60 | 0.33–1.10 | 0.10 |
| (B) | |||
| Age, per 1 year increase | 1.125 | 1.10–1.15 | <0.001 |
| Gender, male vs. female | 1.022 | 0.63–1.66 | 0.93 |
| BMI, per 1 kg/m2 | 1.02 | 0.97–1.08 | 0.46 |
| History of CVD, yes vs. no | 1.56 | 1.05–2.33 | 0.03 |
| Tobacco use, yes vs. no | 1.10 | 0.69–1.76 | 0.69 |
| Hemoglobin, per 1 g/L increase | 1.00 | 0.99–1.01 | 0.80 |
| Serum albumin, per 1 g/L increase | 0.96 | 0.92–1.00 | 0.03 |
| 24–h urine protein, per 1 natural log increase (g/24 h) | 1.01 | 0.87–1.16 | 0.95 |
| Hypertension, yes vs. no | 0.77 | 0.47–1.25 | 0.29 |
| Diabetes, yes vs. no | 1.00 | 0.68–1.46 | 0.98 |
| Triglyceride, per 1 natural log increase (mmol/L) | 1.30 | 0.92–1.85 | 0.14 |
| Cholesterol, per 1 natural log increase (mmol/L) | 1.21 | 0.70–2.09 | 0.51 |
| LDL–C, per 1 natural log increase (mmol/L) | 0.42 | 0.24–0.73 | 0.002 |
| eGFR, per 1 ml/min/1.73m2 increase | 0.994 | 0.985–1.003 | 0.19 |
| Serum uric acid, per 1 umol/L increase | 0.998 | 0.997–1.000 | 0.08 |
| Serum calcium, per 1 mmol/L increase | 2.37 | 0.75–7.53 | 0.14 |
| Serum phosphorus, per 1 natural log increase (mmol/L) | 1.14 | 0.45–2.85 | 0.79 |
| IPTH, per 1 natural log increase (pg/ml) | 0.86 | 0.65–1.15 | 0.31 |
| Calcium–free phosphorus binder, yes vs. no | 0.97 | 0.59–1.58 | 0.89 |
| Active vitamin D, yes vs. no | 1.30 | 0.78–2.17 | 0.31 |
BMI, body mass index; CVD, cardiovascular disease; LDL–C, low–density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate, IPTH: intact parathyroid hormone.